Global Medication Management Market Set To Grow To $2.0 In 2022

06 August 2018
Pharma

Visiongain has launched a new pharma report Global Medication Management Market to 2027: System & Software, Services, Mode of Delivery, Computerised Physician Order Entry, Clinical Decision Support System, Medication Administration Software, Automated Dispensing System, Medication Analytics, Point of Care Verification, Adverse Drug Event Surveillance

The future of the medication management market looks promising, as more and more healthcare providers adopt medication management solutions to reduce the complications in drug administration. Medication management systems are used in hospitals and pharmacies for the prescribing and administering of medicines. Demand for advanced healthcare information and remote patient monitory will propel the medication management market.

The lead analyst of the report commented - “The global medication management market will see steady growth over the forecast period. Growth in the market is primarily driven by the increasing adoption of medication management solutions by hospitals and pharmacies to reduce medication errors, increase in number of prescriptions and increased health care expenditure. However, high costs associated with implementing software and timely gradation and maintenance of these systems may deplete the market to a certain extent.
Asia Pacific is expected to experience the fastest growth owing to large population pool, increased prevalence of infectious diseases, and continued commitment by the government and healthcare providers for better healthcare services.’’

Leading companies featured in the report include Cerner Corporation, GE Healthcare, Epic Systems Corporation, Allscripts Healthcare Solutions, McKesson Corporation, Siemens AG, Braun Melsungen AG, Oracle Corporation, Qualcomm Incorporated, Becton, Dickinson and Company.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever